HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

ATR

AptarGroup, Inc.

Healthcare — Medical Instruments & Supplies

AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations, as well as closures, such as dispensing and non-dispensing solutions that enable product delivery without removal of the cap and used across various consumer end markets. The company also offers aerosol valves used in pressurized containers and continuous spray and metered-dose valves for pharmaceutical, personal care, and household applications; elastomeric primary packaging components; active material science solutions; and digital health solutions. The company primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

None 7 analysts
$120.91
$-0.25 (-0.21%)
Target: $165.43 (36.8%)

Price History

52-Week Range
Sign in to add ATR to a watchlist or set price alerts.

Fundamentals

Market Cap$8.55B
P/E Ratio (TTM)24.14
Forward P/E21.43
EPS (TTM)$5.55
Dividend Yield1.43%
Profit Margin9.22%
Revenue Growth6.30%
ROE13.46%
Debt/Equity51.14
Recommendation None
Analyst Target$165.43
Analysts7
Next Earnings Oct 29, 2026 AMC
Indexes -

Technical Indicators

RSI (14)65.7
Beta-
SMA 20$130.11
SMA 40$125.10
52-Week High$158.12
52-Week Low$103.23
50-Day Avg$123.03
200-Day Avg$125.24
Avg Volume520.0K
Volume620.8K

Performance Analysis

NEUTRAL

ATR presents a mixed picture with both positive and negative indicators.

~ Trading at 32% of its 52-week range.
+ RSI at 65.7 shows positive momentum.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
~ Modest revenue growth of 6.3% year-over-year.
~ Wall Street consensus is "none" from 7 analysts.
+ Average analyst target of $165.43 implies 36.8% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Aug 01, 2026 04:13 UTC

Back to Screener Export Report